Wockhardt P/B Ratio
Wockhardt (WOCKPHARMA) P/B ratio is 5.18 (High), book value per share ₹574.94 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Wockhardt stock price NSE.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
WOCKPHARMA P/B Ratio — Valuation Insights & Book Value Analysis
Wockhardt price-to-book ratio interpretation, valuation status and historical context — current P/B 5.18 (High). View WOCKPHARMA yearly price range for the annual high/low range and current price position.
- Stock appears overvalued with PB of 5.18, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 256.3% above historical average
- Trading at premium to sector average PB of -0.33
Wockhardt P/B Ratio Historical Trend
WOCKPHARMA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with WOCKPHARMA fair value estimate to assess whether the stock is under or overvalued.
WOCKPHARMA Historical P/B Ratio — Book Value Per Share & Year-End Price
Wockhardt annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 2.52 | ₹574.94 | ₹1446.20 | ₹4,657 | Moderate |
| 2024 | 2.98 | ₹475.58 | ₹1416.85 | ₹3,662 | Moderate |
| 2023 | 0.83 | ₹508.61 | ₹424.35 | ₹3,662 | Low |
| 2022 | 0.38 | ₹583.61 | ₹223.05 | ₹4,202 | Low |
| 2021 | 0.56 | ₹683.45 | ₹380.60 | ₹3,759 | Low |
WOCKPHARMA vs Healthcare Peers — P/B Ratio Comparison
Wockhardt P/B 5.18 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Parmax Pharma | PARMAX | -2.48 | ₹14 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.63 | ₹53 | Low |